Group One Trading’s VolitionRx Ltd VNRX Stock Holding History

Group One Trading’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.1K	Hold	2,500	–	–	﹤0.01%	6368
2025 Q4	$12.8K	Buy	+2,500	New	+$19K	﹤0.01%	6668
2022 Q3	–	Sell	-8	Closed	-$303	–	8315
2022 Q2	$0	Hold	8	–	–	﹤0.01%	8588
2022 Q1	$0	Hold	8	–	–	﹤0.01%	8781
2021 Q4	$0	Hold	8	–	–	﹤0.01%	8896
2021 Q3	$0	Hold	8	–	–	﹤0.01%	8846
2021 Q2	$0	Hold	8	–	–	﹤0.01%	8608
2021 Q1	$1K	Buy	+8	New	+$686	﹤0.01%	7484
2020 Q4	–	Sell	-110	Closed	-$7K	–	7047
2020 Q3	$7K	Buy	110 +5	+5%	+$340	﹤0.01%	5549
2020 Q2	$8K	Buy	+105	New	+$7.58K	﹤0.01%	5234

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Group One Trading's VNRX Position: Q1 2026 in Review

Group One Trading held its VolitionRx Ltd (VNRX) position steady in Q1 2026 at 2,500 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6368.

Group One Trading first reported a position in VNRX in Q2 2020 and has held it in 10 quarters since. The position peaked at $12.8K in Q4 2025. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

Group One Trading held 2,500 shares of VolitionRx Ltd worth $10.1K as of Q1 2026.
Group One Trading left its VolitionRx Ltd share count unchanged in Q1 2026.
VolitionRx Ltd made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6368 holding.
Group One Trading first reported a position in VolitionRx Ltd in Q2 2020 and has held it in 10 quarters since.
Group One Trading's VolitionRx Ltd position peaked at $12.8K in Q4 2025.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.